Buy Soliqua Solostar Pens Online

Buy Soliqua Solostar Pens online with a valid prescription, compare current listed pricing, and review the 100/33 SoloStar pen presentation before checkout.

The selected listing shows the strength, pack contents, device format, and handling points that matter for a refrigerated injectable. If you are comparing US delivery from Canada, match the product details on the page to your written order rather than relying on a search result snippet.

Keep the product name, quantity, and prescriber instructions nearby while you review the page. That makes it easier to confirm whether the selected carton, concentration, and pen format are the same item you were prescribed.

Soliqua Solostar Pens Price and Available Options

Start with the current listed price on the product page, then compare the selected presentation and quantity. Soliqua Solostar Pens price comparisons should account for the concentration, pack count, total mL, and whether the listing is for one device or a multi-pen carton.

This product is listed as Soliqua 100/33 in SoloStar prefilled pens. It contains insulin glargine 100 units/mL and lixisenatide 33 mcg/mL, supplied as a 5 x 3 mL presentation. The carton contents are not the same thing as a single injected amount, so use the pack size on the page and the directions on your order instead of estimating from daily use.

If you are evaluating Soliqua 100/33 without insurance, separate the cash-pay amount from coverage, claim, or reimbursement questions. The Soliqua pen cash price shown online can differ from what a plan recognizes, and different product presentations may appear as separate listings. Check the selected strength, quantity, handling charges, and checkout fields before deciding whether the displayed option fits your order.

Customers comparing insulin-only products can browse the Insulin Medications collection to see how those products are organized. Use category browsing for comparison only, because this product is a combination pen rather than insulin glargine alone.

Quick tip: Match the pen name, strength, and pack count before comparing totals.

How to Buy Soliqua Solostar Pens Online

To order Soliqua Solostar Pens online, choose the correct product listing and confirm the 100/33 SoloStar pen details before checkout. Provide the required order information and keep prescriber contact details available in case the product, quantity, or directions need clarification.

Prescription details may be confirmed with your prescriber when needed. Supporting documents may also be requested if the selected product, pack size, or instructions are unclear, especially with combination injectable medicines.

Before submitting checkout details, compare the name on the listing with the name on your written order. Search results may show country-specific cartons or similar insulin pens, but the important check here is the actual presentation: SoloStar pen, insulin glargine plus lixisenatide, and the listed 100/33 concentration.

For refrigerated injectables, address and timing details also matter. Confirm the delivery address, contact information, and availability to receive a temperature-sensitive package. Orders may use express, cold-chain shipping when appropriate, but you should still inspect the package and product condition when it arrives.

Do not rely on a previous insulin order if your clinician changed the prescribed combination, dose range, or pen type. A basal insulin refill and a Soliqua Solostar refill are not interchangeable unless your prescriber has specifically changed the therapy.

Product Details That Affect Ordering

Soliqua is supplied as a prefilled pen injector for subcutaneous injection, which means injection under the skin. It combines insulin glargine, a long-acting basal insulin, with lixisenatide, a glucagon-like peptide-1 receptor agonist, or GLP-1 medicine, that helps improve blood sugar control after meals.

This combination design is why the listing needs a closer check than a standard basal insulin pen. The Soliqua 100/33 pen dose window uses dose steps for this specific product. The number shown on the pen is not a simple mL measurement and should not be converted to a vial, cartridge, or different pen without pharmacist or clinician guidance.

The insulin glargine lixisenatide pen should be inspected before use. Do not use the pen if the solution is cloudy, colored, or contains particles. Do not share a prefilled pen with another person, even if the needle is changed, because shared pens can transmit infection.

Needle compatibility and injection technique are practical ordering checks. If pen needles are listed separately, confirm whether you already have the correct type. General device steps are covered in the Insulin Pen Guide, while your own injection routine should follow the training provided by your care team.

What This Combination Pen Is Used For

Soliqua 100/33 is used with diet and exercise to improve glycemic control in adults with type 2 diabetes. It is not the same as ordering basal insulin alone, and it is not a stand-alone GLP-1 medicine. The combination affects product selection, side effect review, and storage handling.

The treatment is not for type 1 diabetes or diabetic ketoacidosis. It is also not recommended for people with severe stomach-emptying problems, and it has not been studied in people with a history of pancreatitis in the same way as some other diabetes medicines. These points should be considered before starting or continuing the product.

The Type 2 Diabetes product collection can help you browse related diabetes categories. It should not be used to replace the product name, strength, or instructions on your order.

Because this is a Soliqua diabetes pen, product comparisons should begin with the active ingredients. A pen with a similar appearance may contain a different insulin, a different concentration, or no GLP-1 component at all.

Storage, Handling, and Travel Basics

Soliqua SoloStar pens are temperature-sensitive. Unused pens are generally stored in a refrigerator at 2°C to 8°C and should not be frozen. Keep the carton away from direct heat and light, and do not use any pen that has been frozen.

After first use, follow the product label for room-temperature storage and discard the pen after 28 days, even if some medicine remains. Do not store the pen with a needle attached. Removing the needle after each injection helps reduce leakage, air entry, clogging, and contamination risk.

When traveling, keep the pen in a temperature-protected case and avoid placing it directly against ice packs. Airport screening, long car rides, and hotel refrigerators can expose medicine to temperature swings. Carry your prescription details and supplies together so the product can be identified if asked.

Inspect the medicine before each injection. The solution should be clear and colorless. If the pen has been exposed to extreme temperature, shows particles, or looks damaged, contact a healthcare professional or pharmacist for guidance before using it.

Why it matters: Temperature damage can affect medicine quality before the carton looks unusual.

Safety Information Before Buying

Soliqua can cause low blood sugar, especially when used with other glucose-lowering medicines or when meals, activity, illness, or dosing routines change. Symptoms may include shakiness, sweating, confusion, fast heartbeat, hunger, headache, or dizziness. Severe hypoglycemia can require urgent treatment.

This medicine is contraindicated during episodes of hypoglycemia and in people with serious hypersensitivity to insulin glargine, lixisenatide, or any ingredient in the product. Allergic reactions can include rash, swelling, trouble breathing, or severe dizziness. Seek urgent help if symptoms suggest a serious reaction.

Common side effects can include nausea, vomiting, diarrhea, headache, and injection-site reactions. Gastrointestinal effects may be more noticeable when therapy begins or when the body is adjusting. Ongoing vomiting or diarrhea can raise dehydration risk and may affect kidney function.

Pancreatitis has been reported with GLP-1 receptor agonists. Severe abdominal pain that may spread to the back, especially with vomiting, needs prompt clinical attention. Gallbladder problems have also been reported with this medicine class, and symptoms such as right upper abdominal pain, fever, clay-colored stools, or yellowing skin should not be ignored.

Because this product contains insulin, low potassium can occur, especially with medicines that also lower potassium. Fluid retention and heart failure can be a concern when insulin is used with thiazolidinediones, a medicine class that includes pioglitazone and rosiglitazone. These risks belong in the safety discussion before the selected pen is used.

Interactions and Monitoring Checks

Give your clinician and pharmacist a current list of diabetes medicines, heart medicines, diuretics, steroids, antibiotics, supplements, and over-the-counter products. Some medicines can raise blood sugar, while others increase the chance of hypoglycemia. Beta blockers may also make some low-blood-sugar warning signs harder to notice.

Lixisenatide can slow stomach emptying, which may affect the timing or absorption of some oral medicines. Ask how to time medicines that must be taken on a strict schedule. Do not combine this pen with other GLP-1 receptor agonists or change insulin products unless your prescriber has directed the change.

Soliqua is not usually evaluated as an add-on to prandial, or mealtime, insulin. Combining therapies without a clear plan can increase side effect risk or make glucose patterns harder to interpret. Any change involving basal insulin, mealtime insulin, sulfonylureas, or GLP-1 therapy should be directed by the prescribing clinician.

Monitoring usually includes blood glucose checks and periodic A1C testing. Your clinician may also consider kidney function, hydration status, weight changes, gastrointestinal tolerance, potassium levels, and injection-site problems. If readings become unusually high or low, record the timing, meals, activity, and other medicines before contacting your care team.

Ask before using this pen if you are pregnant, planning pregnancy, breastfeeding, have severe stomach problems, have kidney disease, or have a history of pancreatitis. These factors may affect whether the selected product remains appropriate.

Compare Related Diabetes Options

A substitute for Soliqua is not a simple pen swap. The product combines a basal insulin with a GLP-1 medicine, so alternatives differ by active ingredient, device, concentration, side effect profile, and dosing approach. Product substitutions should come from your prescriber.

A basal insulin-only option, such as Lantus SoloStar Pens, contains insulin glargine but does not contain lixisenatide. That difference matters for how the medicine is used and for which side effects or warnings apply.

Another basal insulin pen, Toujeo DoubleStar Prefilled Pen, uses a different insulin glargine concentration and is not the same combination therapy. Compare device format and concentration carefully, but do not select an alternative because the pen looks similar.

The Long-Acting Insulin category can help you review basal insulin products by class. For this listing, the key decision remains whether the exact combination pen, strength, quantity, and handling needs match your order.

Authoritative Sources

Official prescribing information summarizes labeled use, contraindications, warnings, storage, and pen handling: SOLIQUA 100/33 Prescribing Information.

Check the product label whenever there is a question about storage limits, pen use, severe side effects, missed-dose instructions, or whether another diabetes medicine can be used with this combination product.

This content is for informational purposes only and is not a substitute for professional medical advice.

{acf_product_technical_information}